Prograf 0.5 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DR26FNL0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,664
Award facts
- Contract value 100% obligated
- $4,663.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,663.57 on October 20, 2025, for the supply of Prograf 0.5 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider supporting federal medical procurement, particularly for military and veteran healthcare systems. The company's comprehensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major federal vendor, AmerisourceBergen has demonstrated extensive capability in fulfilling federal medical supply requirements through its substantial DLA contract vehicle, which enables global pharmaceutical support for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Prograf, an immunosuppressant medication, exemplifies the company's role in supplying critical pharmaceutical products to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FNL0Q?
SPE2DR26FNL0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FNL0Q worth?
The government has obligated $4,664 on SPE2DR26FNL0Q.
Is contract SPE2DR26FNL0Q an order under another contract?
Yes. SPE2DR26FNL0Q is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL0Q competed?
The extent of competition for SPE2DR26FNL0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award